1bui

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
==Overview==
==Overview==
The serine proteinase plasmin is the key fibrinolytic enzyme that, dissolves blood clots and also promotes cell migration and tissue, remodeling. Here, we report the 2.65 A crystal structure of a ternary, complex of microplasmin-staphylokinase bound to a second microplasmin. The, staphylokinase 'cofactor' does not affect the active-site geometry of the, plasmin 'enzyme', but instead modifies its subsite specificity by, providing additional docking sites for enhanced presentation of the, plasminogen 'substrate' to the 'enzymes's' active site. The activation, loop of the plasmin 'substrate', cleaved in these crystals, can be, reconstructed to show how it runs across the active site of the plasmin, 'enzyme' prior to activation cleavage. This is the first experimental, structure of a productive proteinase-cofactor-macromolecular substrate, complex. Furthermore, it provides a template for the design of improved, plasminogen activators and plasmin inhibitors with considerable, therapeutical potential.
The serine proteinase plasmin is the key fibrinolytic enzyme that, dissolves blood clots and also promotes cell migration and tissue, remodeling. Here, we report the 2.65 A crystal structure of a ternary, complex of microplasmin-staphylokinase bound to a second microplasmin. The, staphylokinase 'cofactor' does not affect the active-site geometry of the, plasmin 'enzyme', but instead modifies its subsite specificity by, providing additional docking sites for enhanced presentation of the, plasminogen 'substrate' to the 'enzymes's' active site. The activation, loop of the plasmin 'substrate', cleaved in these crystals, can be, reconstructed to show how it runs across the active site of the plasmin, 'enzyme' prior to activation cleavage. This is the first experimental, structure of a productive proteinase-cofactor-macromolecular substrate, complex. Furthermore, it provides a template for the design of improved, plasminogen activators and plasmin inhibitors with considerable, therapeutical potential.
 +
 +
==Disease==
 +
Known diseases associated with this structure: Conjunctivitis, ligneous OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173350 173350]], Plasminogen Tochigi disease OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173350 173350]], Plasminogen deficiency, types I and II OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173350 173350]], Thrombophilia, dysplasminogenemic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173350 173350]]
==About this Structure==
==About this Structure==
Line 29: Line 32:
[[Category: staphylokinase]]
[[Category: staphylokinase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 15:57:27 2007''
+
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:14:38 2007''

Revision as of 14:08, 12 November 2007


1bui, resolution 2.65Å

Drag the structure with the mouse to rotate

STRUCTURE OF THE TERNARY MICROPLASMIN-STAPHYLOKINASE-MICROPLASMIN COMPLEX: A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION.

Contents

Overview

The serine proteinase plasmin is the key fibrinolytic enzyme that, dissolves blood clots and also promotes cell migration and tissue, remodeling. Here, we report the 2.65 A crystal structure of a ternary, complex of microplasmin-staphylokinase bound to a second microplasmin. The, staphylokinase 'cofactor' does not affect the active-site geometry of the, plasmin 'enzyme', but instead modifies its subsite specificity by, providing additional docking sites for enhanced presentation of the, plasminogen 'substrate' to the 'enzymes's' active site. The activation, loop of the plasmin 'substrate', cleaved in these crystals, can be, reconstructed to show how it runs across the active site of the plasmin, 'enzyme' prior to activation cleavage. This is the first experimental, structure of a productive proteinase-cofactor-macromolecular substrate, complex. Furthermore, it provides a template for the design of improved, plasminogen activators and plasmin inhibitors with considerable, therapeutical potential.

Disease

Known diseases associated with this structure: Conjunctivitis, ligneous OMIM:[173350], Plasminogen Tochigi disease OMIM:[173350], Plasminogen deficiency, types I and II OMIM:[173350], Thrombophilia, dysplasminogenemic OMIM:[173350]

About this Structure

1BUI is a Protein complex structure of sequences from Homo sapiens. Active as Plasmin, with EC number 3.4.21.7 Structure known Active Sites: ASA and ASB. Full crystallographic information is available from OCA.

Reference

The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action., Parry MA, Fernandez-Catalan C, Bergner A, Huber R, Hopfner KP, Schlott B, Guhrs KH, Bode W, Nat Struct Biol. 1998 Oct;5(10):917-23. PMID:9783753

Page seeded by OCA on Mon Nov 12 16:14:38 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools